$WKHS
Workhorse Group Inc. Stock $wkhs

$wkhs Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000162828023038780 Filed on November 14, 2023

Income Statement

Concept	2023 Q4	2023 Q3
Revenue	$4.406M	$3.029M
YoY Change	27.82%	95.54%
Cost Of Revenue	$18.04M	$6.557M
YoY Change	-14.97%	-31.09%
Gross Profit	-$13.63M	-$3.529M
YoY Change	-23.27%	-55.71%
Gross Profit Margin	-309.36%	-116.52%
Selling, General & Admin	$15.13M	$11.76M
YoY Change	11.82%	-66.17%
% of Gross Profit
Research & Development	$6.412M	$5.772M
YoY Change	-20.33%	-5.8%
% of Gross Profit
Depreciation & Amortization	$1.594M	$1.080M
YoY Change	181.27%	61.67%
% of Gross Profit
Operating Expenses	$21.54M	$17.53M
YoY Change	-0.17%	-57.12%
Operating Profit	-$35.17M	-$21.06M
YoY Change	-10.6%	-56.89%
Interest Expense	-$10.20M	$410.0K
YoY Change
% of Operating Profit
Other Income/Expense, Net		-$10.00M
YoY Change		-174.4%
Pretax Income	-$45.37M	-$30.65M
YoY Change	17.37%	-13.44%
Income Tax	-$110.5K	$0.00
% Of Pretax Income
Net Earnings	-$45.26M	-$30.65M
YoY Change	17.08%	-13.44%
Net Earnings / Revenue	-1027.09%	-1011.9%
Basic Earnings Per Share		-$0.14
Diluted Earnings Per Share	-$0.17	-$0.14
COMMON SHARES
Basic Shares Outstanding	260.9M shares	210.8M shares
Diluted Shares Outstanding		215.9M shares

Balance Sheet

Concept	2023 Q4	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$25.85M	$38.90M
YoY Change	-73.97%	-67.62%
Cash & Equivalents	$25.85M	$38.90M
Short-Term Investments
Other Short-Term Assets	$18.10M	$612.8K
YoY Change	3481.54%	-0.14%
Inventory	$45.41M	$40.78M
Prepaid Expenses
Receivables	$4.470M	$7.424M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$93.83M	$97.78M
YoY Change	-32.67%	-40.08%
LONG-TERM ASSETS
Property, Plant & Equipment	$47.67M	$37.47M
YoY Change	121.72%	119.77%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Other Assets	$176.3K	$176.3K
YoY Change	0.0%	0.0%
Total Long-Term Assets	$47.85M	$48.52M
YoY Change	10.29%	25.37%
TOTAL ASSETS
Total Short-Term Assets	$93.83M	$97.78M
Total Long-Term Assets	$47.85M	$48.52M
Total Assets	$141.7M	$146.3M
YoY Change	-22.47%	-27.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$12.46M	$11.94M
YoY Change	4.75%	54.45%
Accrued Expenses	$5.875M	$5.859M
YoY Change	-86.81%	-86.93%
Deferred Revenue	$4.714M	$4.737M
YoY Change	39.68%	40.35%
Short-Term Debt	$20.18M	$0.00
YoY Change
Long-Term Debt Due	$2.548M
YoY Change
Total Short-Term Liabilities	$53.28M	$25.87M
YoY Change	-15.84%	-57.15%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$5.281M	$7.700M
YoY Change	-51.31%	-24.82%
Total Long-Term Liabilities	$5.281M	$7.700M
YoY Change	-51.31%	-24.82%
TOTAL LIABILITIES
Total Short-Term Liabilities	$53.28M	$25.87M
Total Long-Term Liabilities	$5.281M	$7.700M
Total Liabilities	$58.56M	$33.53M
YoY Change	-21.03%	-52.52%
SHAREHOLDERS EQUITY
Retained Earnings	-$751.6M	-$706.3M
YoY Change	19.76%	19.92%
Common Stock	$286.0K	$255.4K
YoY Change	72.69%	59.17%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$83.11M	$112.8M
YoY Change
Total Liabilities & Shareholders Equity	$141.7M	$146.3M
YoY Change	-22.47%	-27.53%

Cashflow Statement

Concept	2023 Q4	2023 Q3
OPERATING ACTIVITIES
Net Income	-$45.26M	-$30.65M
YoY Change	17.08%	-13.44%
Depreciation, Depletion And Amortization	$1.594M	$1.080M
YoY Change	181.27%	61.67%
Cash From Operating Activities	-$27.48M	-$29.75M
YoY Change	-1.3%	182.88%
INVESTING ACTIVITIES
Capital Expenditures	$2.160M	$6.060M
YoY Change	-72.26%	-249.63%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Cash From Investing Activities	-$2.160M	-$6.060M
YoY Change	-59.33%	-33.04%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	26.62M	12.28M
YoY Change	116.26%	-3366.65%
NET CHANGE
Cash From Operating Activities	-27.48M	-29.75M
Cash From Investing Activities	-2.160M	-6.060M
Cash From Financing Activities	26.62M	12.28M
Net Change In Cash	-3.019M	-23.53M
YoY Change	-85.51%	17.99%
FREE CASH FLOW
Cash From Operating Activities	-$27.48M	-$29.75M
Capital Expenditures	$2.160M	$6.060M
Free Cash Flow	-$29.64M	-$35.81M
YoY Change	-16.81%	453.74%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7424346	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2079343	usd
CY2023Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	0	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	15000000	usd
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	160213944	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	160213944	shares
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	200000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-467214	usd
	us-gaap	Net Income Loss NetIncomeLoss	-78662425	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	112768693	usd
	us-gaap	Net Income Loss NetIncomeLoss	-78662425	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2468832	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1378365	usd
	wkhs	Change In Fair Value And Loss On Exchange Convertible Notes ChangeInFairValueAndLossOnExchangeConvertibleNotes	0	usd
	wkhs	Change In Fair Value And Loss On Exchange Convertible Notes ChangeInFairValueAndLossOnExchangeConvertibleNotes	-1769857	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-143169	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	0	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	10321889	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	8627977	usd
CY2023Q3	us-gaap	Long Term Investments LongTermInvestments	0	usd
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	10000000	usd
CY2023Q3	wkhs	Lease Right Of Use Assets LeaseRightOfUseAssets	10878500	usd
CY2022Q4	wkhs	Lease Right Of Use Assets LeaseRightOfUseAssets	11706803	usd
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	176310	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	176310	usd
CY2023Q3	us-gaap	Assets Assets	146298511	usd
CY2022Q4	us-gaap	Assets Assets	182742475	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	11936156	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	10235345	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5858754	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	46207431	usd
CY2023Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4736831	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3375000	usd
CY2023Q3	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	1777520	usd
CY2022Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	2207674	usd
CY2023Q3	wkhs	Lease Liability Current LeaseLiabilityCurrent	1561769	usd
CY2022Q4	wkhs	Lease Liability Current LeaseLiabilityCurrent	1285032	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	25871030	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	63310482	usd
CY2023Q3	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	0	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	2005000	usd
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	255382128	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1466839	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-2290993	usd
CY2023Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-10000000	usd
CY2022Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	13413500	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-10000000	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	13413500	usd
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.22
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
CY2022Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-142044	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2985275	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-35405501	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	131266183	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	25381078	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-466532	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8627977	usd
	us-gaap	Net Income Loss NetIncomeLoss	-78620308	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1402500	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	131266183	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	107387721	usd
CY2023Q3	wkhs	Shares Issued During Period Value Litigation Settlement SharesIssuedDuringPeriodValueLitigationSettlement	20000000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	8376	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3520404	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-30645712	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	112768693	usd
	wkhs	Shares Issued During Period Value Litigation Settlement SharesIssuedDuringPeriodValueLitigationSettlement	20000000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10321889	usd
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-10000000	usd
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0	usd
	wkhs	Change In Inventory And Prepaid Purchases Reserve ChangeInInventoryAndPrepaidPurchasesReserve	-550090	usd
	wkhs	Change In Inventory And Prepaid Purchases Reserve ChangeInInventoryAndPrepaidPurchasesReserve	-5196774	usd
	wkhs	Noncash Lease Expense NoncashLeaseExpense	583348	usd
	wkhs	Noncash Lease Expense NoncashLeaseExpense	855119	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-200000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-175750	usd
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	5295003	usd
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	16398420	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	28492532	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	6969095	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1083886	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	10317025	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	0	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	84401	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-5563625	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	29650491	usd
	wkhs	Increase Decrease In Extended Warranty Liability IncreaseDecreaseInExtendedWarrantyLiability	-430154	usd
	wkhs	Increase Decrease In Extended Warranty Liability IncreaseDecreaseInExtendedWarrantyLiability	-1244432	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-95546635	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-65979348	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	16527317	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	9708699	usd
	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	0	usd
	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	5000000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16527317	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-14708699	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	52789512	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	248695	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	659582	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	623648	usd
	wkhs	Exercise Of Options And Restricted Share Award Activity ExerciseOfOptionsAndRestrictedShareAwardActivity	-467214	usd
	wkhs	Exercise Of Options And Restricted Share Award Activity ExerciseOfOptionsAndRestrictedShareAwardActivity	-466532	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	51662716	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-841485	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-60411236	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-81529532	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	99276301	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	201647394	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	38865065	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	120117862	usd
CY2023Q3	us-gaap	Prepaid Insurance PrepaidInsurance	1260313	usd
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	1198769	usd
CY2023Q3	us-gaap	Other Assets Current OtherAssetsCurrent	612829	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	505401	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	10705904	usd
	wkhs	Revenue From Contract With Customer Excluding Assessed Tax Net Of Returns And Allowances RevenueFromContractWithCustomerExcludingAssessedTaxNetOfReturnsAndAllowances	8700000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-78700000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-95500000	usd
CY2023Q3	wkhs	Working Capital WorkingCapital	71900000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	38900000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-706300000	usd
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reclassifications</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior period balances have been reclassified to conform to the current year presentation in the unaudited Condensed Consolidated Financial Statements and the accompanying notes. These reclassifications have no effect on previously reported results of operations or stockholders’ equity.</span></div>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, costs and expenses and related disclosures in the accompanying notes.</span></div>
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	14152481	usd
CY2023Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	24032324	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	42500878	usd
CY2023Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	1516984	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	25210131	usd
CY2023Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	17745316	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	301645	usd
CY2023Q3	us-gaap	Inventory Gross InventoryGross	43294624	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	68012654	usd
CY2023Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	2511332	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	59162512	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	40783292	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	8850142	usd
CY2023Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	2500000	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	59200000	usd
CY2023Q3	us-gaap	Contract With Customer Asset Gross Current ContractWithCustomerAssetGrossCurrent	26252384	usd
CY2022Q4	us-gaap	Contract With Customer Asset Gross Current ContractWithCustomerAssetGrossCurrent	34611649	usd
CY2023Q3	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss Current ContractWithCustomerAssetAccumulatedAllowanceForCreditLossCurrent	17419622	usd
CY2022Q4	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss Current ContractWithCustomerAssetAccumulatedAllowanceForCreditLossCurrent	22163338	usd
CY2023Q3	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	8832762	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	12448311	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3028545	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1548798	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8688423	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1575652	usd
CY2023Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	4700000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	5400000	usd
CY2023Q3	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	100000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	200000	usd
CY2022Q3	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	0	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	0	usd
CY2023Q3	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	0	usd
CY2022Q4	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	35000000	usd
CY2023Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2852605	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4967187	usd
CY2023Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3006149	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	6240244	usd
CY2023Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	5858754	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	46207431	usd
CY2023Q2	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	1922580	usd
CY2022Q2	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	3322212	usd
CY2022Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	2207674	usd
CY2021Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	4583916	usd
CY2023Q3	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	289404	usd
CY2022Q3	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	387584	usd
	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	884717	usd
	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	1086542	usd
CY2023Q3	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	144344	usd
CY2022Q3	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	404856	usd
	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	454563	usd
	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	-157890	usd
CY2023Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	1777520	usd
CY2022Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	3339484	usd
CY2023Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	1777520	usd
CY2022Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	3339484	usd
CY2023Q3	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P5Y
CY2023Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	74058	usd
CY2022Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	179704	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	200733	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	603712	usd
CY2023Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	614060	usd
CY2022Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	521566	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	1754557	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	1284533	usd
CY2023Q3	us-gaap	Lease Cost LeaseCost	688118	usd
CY2022Q3	us-gaap	Lease Cost LeaseCost	701270	usd
	us-gaap	Lease Cost LeaseCost	1955290	usd
	us-gaap	Lease Cost LeaseCost	1888245	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5207130	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5884865	usd
CY2023Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	5671370	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	5821938	usd
CY2023Q3	wkhs	Lease Right Of Use Assets LeaseRightOfUseAssets	10878500	usd
CY2022Q4	wkhs	Lease Right Of Use Assets LeaseRightOfUseAssets	11706803	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	6516981	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	6977896	usd
CY2023Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	2703576	usd
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	3147198	usd
CY2023Q3	wkhs	Lease Liability LeaseLiability	9220557	usd
CY2022Q4	wkhs	Lease Liability LeaseLiability	10125094	usd
CY2023Q3	wkhs	Lease Liability Current LeaseLiabilityCurrent	1561769	usd
CY2022Q4	wkhs	Lease Liability Current LeaseLiabilityCurrent	1285032	usd
CY2023Q3	wkhs	Lease Liability Noncurrent LeaseLiabilityNoncurrent	7658788	usd
CY2022Q4	wkhs	Lease Liability Noncurrent LeaseLiabilityNoncurrent	8840062	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	17500000	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	2900000	shares
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3520404	usd
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2985275	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10321889	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8627977	usd
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	50200	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.1
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	80997	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.7
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	292429	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	10.3
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P8Y3M18D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	204213	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	10.3
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P8Y3M18D
CY2022Q1	wkhs	Sale Of Stock Authorized Amount SaleOfStockAuthorizedAmount	175000000	usd
CY2023Q3	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	24600000	shares
	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	63300000	shares
CY2023Q3	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	12500000	usd
	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	52800000	usd
CY2022Q3	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	100000	shares
	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	100000	shares
CY2022Q3	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	200000	usd
	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	200000	usd
CY2023Q3	wkhs	Sale Of Stock Remaining Authorized Amount SaleOfStockRemainingAuthorizedAmount	108000000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	0	usd
CY2023Q3	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	0	usd
CY2023Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001628280-23-038780-index-headers.html	Edgar Link	pending
0001628280-23-038780-index.html	Edgar Link	pending
0001628280-23-038780.txt	Edgar Link	pending
0001628280-23-038780-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
wkhs-20230930.htm	Edgar Link	pending
wkhs-20230930.xsd	Edgar Link	pending
wkhs-20230930xexx311.htm	Edgar Link	pending
wkhs-20230930xexx312.htm	Edgar Link	pending
wkhs-20230930xexx321.htm	Edgar Link	pending
wkhs-20230930xexx322.htm	Edgar Link	pending
wkhs-20230930_def.xml	Edgar Link	unprocessable
wkhs-20230930_cal.xml	Edgar Link	unprocessable
wkhs-20230930_lab.xml	Edgar Link	unprocessable
wkhs-20230930_pre.xml	Edgar Link	unprocessable
wkhs-20230930_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$WKHS
Workhorse Group Inc. Stock $wkhs

2023 Q4 Form 10-Q Financial Statement

#000162828023038780 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$WKHS Workhorse Group Inc. Stock $wkhs

2023 Q4 Form 10-Q Financial Statement

#000162828023038780 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$WKHS
Workhorse Group Inc. Stock $wkhs